ZL-1211

· Zai Biopharmaceutical (Suzhou) Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ZL-1211, covering 2024-09-03 to 2024-09-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study of ZL-1211 in Patients With Advanced Solid Tumor [Phase 1]